5BLOM Y, HELDIN E. Direct resolution of racemic drugs using cellulase silica as a chiral stationary phase[J]. Journal of Chromatography A, 1993, 653 ( 1 ) : 138-143.
4Anderson JL,Platia EV,Hallstrom A,et al.Interaction of baseline characteristics with the hazard of encainide,flecainide,and moricizine therapy in patients with myocardial infarction a possible explana-tion for increased mortality in the cardiac arrhythmia suppression trial(CAST)[J].Circulation,1994,90:2 843.
5Leung MW,Chan AP,So PP,et al.Effects of flecainide on atrial and ventricular refractoriness in rabbits in vitro and in vivo[J].Proc West Pharmacol Soc,2004,47:42.
6Gupta P,Patel C,Patel H,et al.Tp-e/OT ratio as an index of arrhythmogenesis[J].J Electrocardiol,2008,41(6):567.
7Wang DY,Chae SW,Gong QY,et al.Role of aiNa in positive force-frequency staircase in guinea pig papillary muscle[J].Am J Physid Cell Physiol,1988,255:C798.
8Kihara Y,Inoko M,Hatakeyanm N.Mechanisms of negative inotropic effects of class Ic antiarrhythmic agents:comparative study of the effects of flecainide and pilsicainide on intracellular calcium handling in dog ventricular myocardium[J].J Cardiovasc Pharmacol,1996,27(1):42.
9Ito K,Nagafuchi K,Taga A,et al.Possible involvement of altered Na^+-Ca^2+exchange in negative inotropic effects of class Ⅰ antiarrhythmic drugs on rabbit and rat ventricles[J].J Cardiovasc Pharmacol,1996,27(3):355.
10Watanabel H,Chopra N,Laver D,et al.Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans[J].Nature Medicine,2009,15:380.
